Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2020-08-05 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
1. Newspaper advertisement for Notice of 57th Annual General Meeting, Remote E-Voting and Book Closure 2. Extract of Financial Results for the Quarter Ended June 30, 2020
Regulatory Filings
2020-08-05 English
1.The 57th Annual General Meeting (AGM) of the Members of Unichem Laboratories Limited will be held on Saturday, August 29, 2020 at 11:30 a.m. through video conference ('VC')/ Other Audio ....
Annual Report Classification · 95% confidence The document is a communication dated August 4, 2020, referencing the 57th Annual General Meeting (AGM) of Unichem Laboratories Limited. It includes the Annual Report for the fiscal year ended March 31, 2020, along with the AGM notice. The text contains detailed sections typical of an Annual Report, such as a message from the Chairman, corporate social responsibility activities, board committees, statutory auditors, and financial highlights. The document is lengthy (15,000 characters) and contains substantive content rather than just an announcement or a brief notice. It explicitly states it is the Annual Report 2019-2020 and includes comprehensive information about the company's operations, governance, and financial performance. Therefore, this document is the full Annual Report rather than a mere announcement or notice related to the AGM or report publication. FY 2020
2020-08-04 English
Unaudited Financial Results (Standalone & Consolidated) for the first quarter ended June 30, 2020
Regulatory Filings
2020-08-04 English
Financial Result Updates
Regulatory Filings
2020-08-04 English
Copy of Newspaper Publication
Regulatory Filings
2020-07-31 English
Notice to the Members of the 57th Annual General Meeting to be held through Video Conference CVC''V Other Audio Visual Means (''OVAM'')
Regulatory Filings
2020-07-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.